24 August, 2014 01:17 IST
News
Aurobindo reports loss of Rs 285.4 mn in Q3
Source: IRIS (14-FEB-12)
Comments  |  Post Comment

Aurobindo Pharma has posted consolidated net loss of Rs. 285.40 million for the quarter ended December 31, 2011 as compared to net profit of Rs. 1,886.30 million for the quarter ended December 31, 2010.

Total Income has increased by 7.62% from Rs. 11,980.80 million for the quarter ended December 31, 2010 to Rs. 12,894.50 million for the quarter ended December 31, 2011.

The company has posted a standalone net profit of Rs. 129.30 million for the quarter ended December 31, 2011 as compared to Rs. 1,838.50 million for the quarter ended December 31, 2010, registering a sharp fall of 92.96%. Total Income has increased by 4% from Rs. 11,576.60 million for the quarter ended December 31, 2010 to Rs. 12,031.80 million for the quarter ended December 31, 2011.

Shares of the company declined Rs 1.2, or 1.08%, to settle at Rs 109.45. The total volume of shares traded was 274,773 at the BSE.



Aurobindo Pharma Limited   (Q,N,C,F)*


News
Merrill Lynch picks 2.32 lakh shares in Welspun Projects - 22-Aug-2014 18:02
'Buy' Entertainment Network; target Rs 490: ICICIdirect - 22-Aug-2014 16:55
NSE, BSE exclude United Spirits from F&O segment - 22-Aug-2014 15:53
Sonata arm to acquire controlling stake in Rezopia - 22-Aug-2014 15:41
ICICI Bank allots share under ESOS - 22-Aug-2014 15:17
Cyient to acquire majority stake in Invati Insights - 22-Aug-2014 14:47
MICROSEC sees 32% upside potential in Whirlpool of India - 22-Aug-2014 13:29
Karnataka Bank inks pact with NBHC to extend collateral management services - 22-Aug-2014 13:23
Tilaknagar Industries clarifies on news report - 22-Aug-2014 13:03
Dairy business could be very attractive opportunity for ITC: Nomura - 22-Aug-2014 12:08
HDFC Sec raises TCS target price by 10% - 22-Aug-2014 11:35
more...
* Q - Quote , N - News , C - Chart , F - Financials
Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type   svgthj into this box
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Forums  |   E-mail  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer